The effects of maternal position during induction of combined spinal-epidural anesthesia for cesarean delivery.

UNLABELLED: Combined spinal-epidural anesthesia (CSE) is a popular technique for cesarean delivery. Regional blocks in obstetrics are often performed with the parturient in the sitting position because the midline may be recognized more easily than in the lateral decubitus position. When conventional spinal anesthesia is performed in the sitting position, the patient is placed supine immediately after drug injection. In contrast, when CSE is performed with the woman sitting, there is a delay in assuming the supine position because of epidural catheter placement, which may affect the incidence of hypotension. Healthy women, at term of pregnancy, about to undergo an elective cesarean section under CSE, were randomly assigned to the sitting or lateral recumbent position for initiation of the block. All parturients were given 1000 mL of lactated Ringer's solution in the 15 min preceding induction and an additional 300-500 mL while the actual block was being performed. On completion of the CSE, they were turned to the supine position with left uterine displacement. A second anesthesiologist, blinded to the woman's position during CSE, evaluated the sensory level of anesthesia, maternal heart rate, blood pressure, oxygen saturation, need for ephedrine, and occurrence of nausea and vomiting. Results are expressed as mean +/- SD. Twelve women were studied in the sitting group and 10 were studied in the lateral recumbent group. The severity and duration of hypotension were greater in those parturients who had CSE induced in the sitting (47%+/-7% and 6+/-3 min, respectively) compared with the lateral recumbent position (32%+/-14% and 3+/-2 min, respectively). Women in the sitting group also required twice as much ephedrine (38+/-18 mg) to correct hypotension compared with the other group (17+/-12 mg). In conclusion, the severity and duration of hypotension were greater when CSE was induced in the sitting compared with the lateral decubitus position. IMPLICATIONS: We studied the induction of combined spinal-epidural anesthesia (CSE) in the sitting versus lateral recumbent positions in healthy women undergoing a scheduled cesarean delivery. The severity and duration of hypotension were greater when CSE was induced in the sitting position. Thus, the position used for induction of CSE should be among the factors considered when there is greater maternal or fetal risk from hypotension.

New amide local anaesthetics for obstetric use.

For a number of reasons, bupivacaine has become the most frequently used local anaesthetic in obstetric anaesthesia, despite the fact that it has a narrower margin of safety than other local anaesthetics. In recent years, advances in technology have made single-isomer formulations of drugs available for clinical use. Generally speaking, the levo stereoisomer of amide local anaesthetic has a lower potential for systemic toxicity than the dextro form of the drug while retaining anaesthetic potency. Ropivacaine (Naropin, Astra Ltd), a homologue of mepivacaine and bupivacaine, has recently been released for use. Its clinical efficacy appears to be quite similar to that of bupivacaine but it has a greater margin of safety. The other drug currently being investigated is levobupivacaine (Chirocaine, Chiroscience Ltd). Both drugs appear to be similar in efficacy to the currently used formulation of bupivacaine; however, they are more costly. Thus, cost-benefit analyses are required to define more clearly their future role in obstetric anaesthesia.

The effects of bupivacaine, L-nitro-L-arginine-methyl ester, and phenylephrine on cardiovascular adaptations to asphyxia in the preterm fetal lamb.

UNLABELLED: The preterm fetal lamb that is exposed to clinically relevant plasma concentrations of lidocaine loses its cardiovascular adaptations to asphyxia, and its condition deteriorates further. Nitric oxide (NO) is an important regulator of vascular tone, and local anesthetics are known to inhibit endothelium-dependent vasodilation. The purpose of the present study was to determine whether the adverse effects of lidocaine noted in the preterm fetal lamb also occur with bupivacaine and whether the inhibition of NO results in effects similar to those of bupivacaine. Thirty-two chronically prepared pregnant sheep were studied at 117-119 days' gestation. Maternal and fetal blood pressure, heart rate, and acid-base state were evaluated. Fetal organ blood flows were determined using 15-microM diameter dye-labeled microspheres. After a control period, mild to moderate asphyxia (fetal PaO2 15 mm Hg) was induced by partial umbilical cord occlusion and maintained throughout the experiment. Ewes in Group I (n = 13) were given a two-step intravenous infusion of bupivacaine for 180 min. Fetuses in Group II (n = 12) received an intravenous injection of L-nitro-L-arginine-methyl ester (L-NAME) (25 mg/kg), and measurements were taken 10 and 30 min after the injection. A third group (Group III) of fetuses (n = 7) were given an intravenous infusion of phenylephrine to mimic the blood pressure increases noted in L-NAME-treated fetuses. At 90 min of stable asphyxia, there was a significant decrease in fetal PaO2 and pHa and an increase in PaCO2 and mean arterial blood pressure. There was also an increase in blood flow to the adrenals, myocardium, and cerebral cortex, whereas blood flow to the placenta decreased. Administration of bupivacaine during asphyxia did not affect the changes in mean arterial blood pressure and acid-base state but did abolish the increases in blood flows to the myocardium and cerebral cortex. Injection of L-NAME to the asphyxiated fetus resulted in an increase in mean arterial blood pressure above the level noted at 90 min of cord occlusion, and an increase in fetal PaO2 toward control levels. This was accompanied by a reduction in organ blood flows to preasphyxia levels. In asphyxiated Group III fetuses, titration of the phenylephrine infusion to achieve blood pressure increases similar to those noted with L-NAME were also associated with an increase in fetal PaO2. These data indicate that bupivacaine abolishes some of the circulatory adaptations to mild to moderate asphyxia induced by partial cord occlusion in the preterm fetal lamb. It is not clear whether these effects of bupivacaine are due to inhibition of NO. IMPLICATIONS: In the preterm fetal lamb, clinically relevant plasma concentrations of bupivacaine achieved by intravenous infusion to the pregnant ewe (80% gestation) abolished some of the fetal cardiovascular adaptations to asphyxia induced by partial umbilical cord occlusion.